Compare PLRX & NEOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLRX | NEOV |
|---|---|---|
| Founded | 2015 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.3M | 137.2M |
| IPO Year | 2020 | N/A |
| Metric | PLRX | NEOV |
|---|---|---|
| Price | $1.29 | $4.68 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 11 | 1 |
| Target Price | ★ $3.79 | N/A |
| AVG Volume (30 Days) | ★ 934.5K | 276.9K |
| Earning Date | 03-02-2026 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $14,486,857.00 |
| Revenue This Year | N/A | $148.14 |
| Revenue Next Year | N/A | $6.34 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 486.23 |
| 52 Week Low | $1.10 | $1.80 |
| 52 Week High | $12.88 | $6.19 |
| Indicator | PLRX | NEOV |
|---|---|---|
| Relative Strength Index (RSI) | 46.70 | 63.80 |
| Support Level | $1.26 | $3.40 |
| Resistance Level | $1.38 | $4.20 |
| Average True Range (ATR) | 0.06 | 0.41 |
| MACD | 0.01 | 0.13 |
| Stochastic Oscillator | 46.83 | 85.28 |
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.